Early Scan Saves UK Woman After Sister’s Tragic Cancer Death

A woman living in Texas credits an early breast cancer screening—prompted by her sister’s tragic death from cancer—for saving her life. Katie Allen, 33, originally from the UK and now based in Corpus Christi, underwent a thorough health check after her older sister, Jen Bekker, died following an aggressive battle with ovarian cancer.

Family Tragedy Spurs Life-Saving Action

Katie sought a health “MOT” after caring for Jen, 36, whose initial pelvic symptoms were misdiagnosed before a private scan found ovarian cancer in November 2023. Despite chemotherapy, radiotherapy, and immunotherapy, Jen’s cancer metastasized to her brain. She died March 1, 2025, after a final family trip to South Africa with her young daughter.

“It was a gift from Jen,” Katie said, reflecting on how her sister’s ordeal motivated her to get checked.

Cancer Detected Early, Thanks To American Screening

Back in the US, and still grieving, Katie underwent health screenings in April 2025—including a mammogram she would have been too young to access without symptoms under the UK’s National Health Service (NHS). In the UK, women are typically first invited for breast screening between ages 50 and 53. Katie’s scan revealed abnormal tissue—despite her not having found a lump or experiencing symptoms.

A biopsy in May confirmed breast cancer, and further tests showed she carries the BRCA2 gene mutation, which greatly increases the lifetime risk of developing breast and ovarian cancer. Women with BRCA2 variants face a 61–77% chance of developing breast cancer by age 80—compared to around 15% in the general population.

Tough Treatment Ahead

Katie began intensive chemotherapy just one day after diagnosis, facing 16 sessions over 20 weeks with further surgery likely. Carrying the BRCA2 mutation means she may need a double mastectomy or even removal of her ovaries, as the gene substantially raises the risk of recurrence and new cancers.

Despite her ordeal, Katie remains grateful for having been able to access screening in the US—screening that could have been delayed for years in the UK unless she was formally classified as “very high risk,” a status now addressed in updated NHS guidelines as of April 2025. These guidelines allow women with proven BRCA gene variants to receive earlier and more frequent screenings from age 25, but the standard population pathway in the UK remains age 50+.

ADVERTISEMENT

“Luck Helped Find My Cancer Early”

“If I was still back home, I’d have had to wait until the lump was bigger,” Katie stated. “I’m lucky it was caught when it was.” She continues to be supported by her husband, Cody, as she faces the path ahead.

Jen Bekker, remembered as an “absolute fighter,” leaves behind her young daughter and a sister determined that her own story will encourage others to seek critical early screening—even in the absence of symptoms.